Literature DB >> 30209179

Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling.

Shu-Xiang Wu1, Wan-Nan Chen1, Zhen-Tang Jing1, Wei Liu1, Xin-Jian Lin1, Xu Lin2,3.   

Abstract

Hepatitis B spliced protein (HBSP) is known to associate with viral persistence and pathogenesis; however, its biological and clinical significance remains poorly defined. Acquired resistance to Fas-mediated apoptosis is thought to be one of the major promotors for hepatitis B virus (HBV) chronicity and malignancy. The purpose of this study was to investigate whether HBSP could protect hepatocytes against Fas-initiated apoptosis. We showed here that HBSP mediated resistance of hepatoma cells or primary human hepatocytes (PHH) to agonistic anti-Fas antibody (CH11)- or FasL-induced apoptosis. Under Fas signaling stimulation, expression of HBSP inhibited Fas aggregation and prevented recruitment of the adaptor molecule Fas-associated death domain (FADD) and procaspase-8 (or FADD-like interleukin-1β-converting enzyme [FLICE]) into the death-inducing signaling complex (DISC) while increasing recruitment of cellular FLICE-inhibitory protein L (FLIPL) into the DISC. Those effects may be mediated through activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway as evidenced by increased cellular phosphatidylinositol (3,4,5)-trisphosphate (PIP3) content and PI3K activity and enhanced phosphorylation of mTORC2 and PDPK1 as well as Akt itself. Confirmedly, inhibition of PI3K by LY294002 reversed the effect of HBSP on Fas aggregation, FLIPL expression, and cellular apoptosis. These results indicate that HBSP functions to prevent hepatocytes from Fas-induced apoptosis by enhancing PI3K/Akt activity, which may contribute to the survival and persistence of infected hepatocytes during chronic infection.IMPORTANCE Our study revealed a previously unappreciated role of HBSP in Fas-mediated apoptosis. The antiapoptotic activity of HBSP is important for understanding hepatitis B virus pathogenesis. In particular, HBV variants associated with hepatoma carcinoma may downregulate apoptosis of hepatocytes through enhanced HBSP expression. Our study also found that Akt is centrally involved in Fas-induced hepatocyte apoptosis and revealed that interventions directed at inhibiting the activation or functional activity of Akt may be of therapeutic value in this process.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Akt; Fas; HBSP; apoptosis; viral persistence

Mesh:

Substances:

Year:  2018        PMID: 30209179      PMCID: PMC6232459          DOI: 10.1128/JVI.01273-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.

Authors:  Hye Jin Kim; Sang Yong Kim; Jinchul Kim; Heemin Lee; Misun Choi; Jeong Ki Kim; Jeong Keun Ahn
Journal:  IUBMB Life       Date:  2008-07       Impact factor: 3.885

Review 2.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

3.  X-gene product of hepatitis B virus induces apoptosis in liver cells.

Authors:  H Kim; H Lee; Y Yun
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

4.  The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis.

Authors:  Patrick Soussan; Rosella Tuveri; Bertrand Nalpas; Florianne Garreau; Flora Zavala; Annie Masson; Stanislas Pol; Christian Brechot; Dina Kremsdorf
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

5.  Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression.

Authors:  A Suzuki; M Hayashida; H Kawano; K Sugimoto; T Nakano; K Shiraki
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 7.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

Review 8.  Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Authors:  Madhu Ramaswamy; Sophia Y Cleland; Anthony C Cruz; Richard M Siegel
Journal:  Results Probl Cell Differ       Date:  2009

9.  Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner.

Authors:  Anice Moumen; Alessandro Ieraci; Salvatore Patané; Carme Solé; Joan X Comella; Rosanna Dono; Flavio Maina
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

10.  High level expression of apoptosis inhibitor in hepatoma cell line expressing Hepatitis B virus.

Authors:  Xuanyong Lu; Matthew Lee; Trang Tran; Timothy Block
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more
  6 in total

Review 1.  Hepatitis B virus e antigen and viral persistence.

Authors:  Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Curr Opin Virol       Date:  2021-10-28       Impact factor: 7.090

2.  IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways.

Authors:  Yang Song; Ming Yang; Hongjian Zhang; Yan Sun; Ye Tao; Huihui Li; Jing Zhang; Yuncheng Li; Jianming Yang
Journal:  J Immunol Res       Date:  2020-12-18       Impact factor: 4.818

3.  Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy.

Authors:  Jiacheng Lin; Limin Yin; Xia-Zhen Xu; He-Chen Sun; Zhi-Hua Huang; Xue-Yun Ni; Yan Chen; Xu Lin
Journal:  PLoS Pathog       Date:  2022-01-14       Impact factor: 6.823

4.  Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.

Authors:  Olivia Maslac; Josef Wagner; Vitina Sozzi; Hugh Mason; Jenny Svarovskaia; Susanna Tan; Anuj Gaggar; Stephen Locarnini; Lilly Yuen; Margaret Littlejohn; Peter A Revill
Journal:  J Viral Hepat       Date:  2022-05-28       Impact factor: 3.517

5.  Rg1 protects H9C2 cells from high glucose-/palmitate-induced injury via activation of AKT/GSK-3β/Nrf2 pathway.

Authors:  Haitao Yu; Juan Zhen; Yang Yang; Jian Du; Jiyan Leng; Qian Tong
Journal:  J Cell Mol Med       Date:  2020-06-16       Impact factor: 5.310

Review 6.  Pathogenicity and virulence of Hepatitis B virus.

Authors:  Yu-Chen Chuang; Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.